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Abstract
Background: Although the sequence of events leading to wound repair has been described at the
cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated.
Genome wide transcriptional analysis tools promise to further define the global picture of this
complex progression of events.
Study Design: This study was part of a placebo-controlled double-blind clinical trial in which basal
cell carcinomas were treated topically with an immunomodifier – toll-like receptor 7 agonist:
imiquimod. The fourteen patients with basal cell carcinoma in the placebo arm of the trial received
placebo treatment consisting solely of vehicle cream. A skin punch biopsy was obtained
immediately before treatment and at the end of the placebo treatment (after 2, 4 or 8 days). 17.5K
cDNA microarrays were utilized to profile the biopsy material.
Results: Four gene signatures whose expression changed relative to baseline (before wound
induction by the pre-treatment biopsy) were identified. The largest group was comprised
predominantly of inflammatory genes whose expression was increased throughout the study. Two
additional signatures were observed which included preferentially pro-inflammatory genes in the
early post-treatment biopsies (2 days after pre-treatment biopsies) and repair and angiogenesis
genes in the later (4 to 8 days) biopsies. The fourth and smallest set of genes was down-regulated
throughout the study. Early in wound healing the expression of markers of both M1 and M2
macrophages were increased, but later M2 markers predominated.
Conclusion: The initial response to a cutaneous wound induces powerful transcriptional
activation of pro-inflammatory stimuli which may alert the host defense. Subsequently and in the
absence of infection, inflammation subsides and it is replaced by angiogenesis and remodeling.
Understanding this transition which may be driven by a change from a mixed macrophage
population to predominately M2 macrophages, may help the interpretation of the cellular and
molecular events occurring in the microenvironment of serially biopsied tissues.
Published: 21 February 2007
Journal of Translational Medicine 2007, 5:11 doi:10.1186/1479-5876-5-11
Received: 16 November 2006
Accepted: 21 February 2007
This article is available from: http://www.translational-medicine.com/content/5/1/11
© 2007 Deonarine et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11
(page number not for citation purposes)
Journal of Translational Medicine 2007, 5:11 http://www.translational-medicine.com/content/5/1/11Background
In the classical model of wound healing four overlapping
phases are described: hemostasis, inflammation, prolifer-
ation, and remodeling [1]. Cutaneous wounds are associ-
ated with a series of cellular responses that include blood
clotting, platelet activation, inflammatory cell infiltration,
re-epithelization and the formation of granulation tissue
made up of fibroblasts and blood vessels. The later stages
of healing include matrix deposition and wound contrac-
tion and re-epithelialization [1-4].
In skin, wound healing begins with hemostasis marked by
the appearance of platelets [1]. A platelet aggregate is
formed at the site of the wound and activated platelets
release cytokines involved with wound healing such as
platelet-derived growth factor (PDGF) and transforming
growth factor beta (TGF-β). At the site of the platelet clot,
coagulation system enzymes are activated and fibrinogen
is converted to fibrin. The resulting network forms the
provisional matrix for tissue repair [5]. Several hours after
clot formation, keratinocytes begin to move into the site
from the edges of the injury to begin to close the wound
[6]
The inflammatory response includes neutrophils, macro-
phages, and mast cells. Neutrophils are first to infiltrate
the site of the wound. Within 24 hours neutrophils
become the predominant leukocyte in the wound where
they remove foreign material, bacteria, and damaged
matrix [1]. Tissue macrophages arrive within 48 hours and
produce both cytokines and growth factors. They also play
a role in deébridement, acting as phagocytes to clear away
matrix deébris. The appearance of activated macrophages
is accompanied by the appearance of lymphocytes and
marks the end of the inflammatory phase and the begin-
ning of the proliferative phase of wound healing.
The proliferative phase is associated with the production
of collagen, proteoglycans and fibronectin to form new
extracellular matrix, continue epithelization, and angio-
genesis. Fibroblasts, which produce matrix and collagen,
are the predominant cell in this phase. TGB-β which is
produced by platelets, macrophages, and T cells is a
potent stimulus of fibroblasts and plays a critical role in
the proliferative phase [3]. Angiogenesis begins with the
migration of endothelial cells into the fibrin matrix.
Endothelial cells begin to degrade the interstitial matrix in
order to form new capillaries. TGF-β along with vascular
endothelial growth factor (VEGF) and basic fibroblast
growth factor stimulate angiogenesis [3].
The final phase of wound healing, remodeling, involves
the degradation of collagen by proteolytic enzymes pro-
duced by fibroblasts, neutrophils and macrophages. This
phase is also characterized by the infiltration of mast cells
which manage host wound repair through increased
inflammatory signaling [1].
Although wound healing is a complex process involving
hemostasis, inflammation, cell proliferation, cell migra-
tion, and tissue remodeling, most studies of wound heal-
ing have focused on specific cells or specific proteins or
genes. In this study of wound healing the expression of a
broad spectrum of genes was assessed before and over 2,
4 and 8 days after a skin wound. Samples were obtained
as part of a placebo-controlled double-blind study of gene
expression profiling of basal cell carcinoma treated topi-
cally with Imiquimod, a drug whose activity is mediated
through toll-like receptor 7 (TLR-7) signaling [7]. We
studied fourteen patients with basal cell carcinoma in the
placebo group who were treated topically with control
cream using treatment schedules of 2, 4 or 8 days. In each
of the fourteen patients studied, a skin punch biopsy was
obtained immediately before treatment was started and at
the end of the placebo treatment period. Gene expression
cDNA microarrays were used to analyze the skin punch
biopsies of tissue taken from the basal cell carcinoma of
each patient. Since the skin biopsies were taken immedi-
ately adjacent to each other, the initial skin biopsies were
considered to be pre-wound and the second biopsy was
considered to represent the host response to the wound.
Materials and methods
Study design
Skin biopsies were obtained from 14 subjects belonging
to the control group of a double-blind clinical trial in
which basal cell carcinomas were treated topically with
the immunomodifier-TLR-7 agonist: imiquimod [7]. The
basal cell carcinoma was located on the proximal extrem-
ities, trunk, scalp or face and was at least 7 mm in diame-
ter. Placebo cream covering at least 2 cm was applied to
the basal cell carcinoma for either 2, 4, or 8 days (Table 1).
Punch biopsies (2 mm) of the basal cell carcinomas were
performed at the beginning of the study and approxi-
mately 12 hours after the final application of placebo
(Table 1). The first (pre-wound) biopsy was considered to
create the wound and the second biopsy, which was sub-
sequently taken immediately adjacent to the first biopsy,
was considered the host response to that wound (post-
wound). Among the 14 patients, three were biopsied on
day 2, seven on day 4, and four on day 8. Gene expression
profiling was performed on the pre- and post-treatment
punch biopsies obtained from the 14 control patients.
RNA was amplified and hybridized to 17.5K cDNA arrays.
RNA isolation and amplification and cDNA microarray 
analysis
Total RNA was isolated with RNeasy minikits (Qiagen,
Germantown, MD) and amplified into anti-sense RNA as
previously described [8,9] with the following modifica-Page 2 of 11
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RNAases. Samples were homogenized in disposable tissue
grinders (Fisher Scientific, Lafayette, CO, USA). Proteins
potentially interfering with RNA isolation were removed
by incubating the homogenate in 590 μl distilled water
and 10 μl PROTEINASE K solution (Qiagen) at 55°C for
10 minutes then centrifuged at ambient temperature for 3
minutes. Supernatants were combined with 0.5 volumes
of ethanol (96–100%) into a Rnase-Dnase free tube and
RNA was isolated through a RNeasy mini column. First
strand cDNA synthesis was accomplished in 1 μl SUPER-
aseIn (Ambion, Austin, Tx, USA) and ThermoScript RT
(Gibco BRL, Gaithersburg, MD, USA) in 2 μg bovine
serum albumin. RNA quality was verified by Agilent tech-
nologies (Palo Alto, CA). Anti-sense RNA was used for
probe preparation Test samples were labeled with Cy5-
dUTP (Amersham, Piscataway, NJ, USA) and co-hybrid-
ized with reference pooled normal donor peripheral
blood mononuclear cells (PBMC) labeled with Cy3-dUTP
to custom made 7K-cDNA microarrays [10]. Arrays were
scanned on a GenePix 4000 (Axon Instruments, Union
City, CA) and analyzed using Cluster and Tree View soft-
ware [11]. Gene ratios are presented according to the cen-
tral method for display [12]. Gene annotations were
mined using the following web-based tools [13-16].
Statistical analysis
Significance testing was based on paired or 2-sample two-
tailed Student t tests as appropriate. P-values < 0.05 were
considered statistically significant. Microarray raw data
was curated according to GEO [17].
Results
Gene expression profiles in skin before and after a wound
Pre- and post-wound gene expression profiles were com-
pared in skin biopsies from 14 subjects with basal cell car-
cinoma using unsupervised hierarchical clustering. Eisen's
correlation and clustering was applied to the 17.5K global
data set using various filtering parameters, however, inde-
pendent of the filter applied, no correlation or molecular
signatures that separated pre- and post-wound samples
was identified. Pre- and post-wound samples from 4 of
the 14 subjects clustered as pairs indicating that in some
cases differences between subjects were greater than differ-
ences within a subject due to wound healing (data not
shown).
Gene expression profiles were then analyzed using super-
vised clustering on the global data set and by Student t
tests (cutoff p-value < 0.05 between genes expressed in
pooled pre-versus post-wound samples). Supervised
Eisen's correlation and clustering revealed that the expres-
sion of most of the genes was either increased or
unchanged in the post-wound samples. Comparison by
paired Student t tests identified 1,749 genes differentially
expressed between pre- and post-wound samples. Filter-
ing of this gene set identified 753 transcripts that were
expressed in 80% of the samples and were differentially
expressed between pre- and post-treatment biopsy at least
2 or more fold. Visual inspection identified 7 prominent
signatures containing a total of 120 genes (Figure 1).
Two clusters included predominantly transcripts who
expression was increased early on day 2 after wounding
(Figure 2, clusters 3 and 4) and represented a wide variety
of pro-inflammatory genes. Several markers were present
indicating TNF activation (TNF receptor associated factor
1,2) and interferon (IFN) activation, (AIF1 and IFIT2).
The expression of several macrophage markers was
increased (CD163, FcγRI, macrophage scavenger receptor
1, and MHC class II α chain) as were markers of T cells
(RAB7L1, and RAB18), B cells (immunoglobulin heavy
Table 1: Duration and Schedule of Topical Placebo Application
Patient Placebo Application Schedule Doses of Placebo Cream
P10 Every 12 hr × 2 days 4
P23 Every 12 hr × 2 days 2
P26 Every 12 hr × 2 days 4
P41 Every 12 hr × 4 days 8
P134 Every 12 hr × 4 days 8
P8 Every 12 hr × 4 days 8
P20 Every 12 hr × 4 days 8
P4 Every 24 hr × 4 days 4
P13 Every 24 hr × 4 days 4
P36 Every 24 hr × 4 days 4
P2 Every 24 hr × 8 days 8
P15 Every 24 hr × 8 days 8
P27 Every 24 hr × 8 days 8
P137 Every 24 hr × 8 days 8Page 3 of 11
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the expression of β2 integrin, CD18, which is found on
many different leukocytes, was increased. Evidence of tis-
sue repair was also present including the presence of the
cysteine protease, cathepsin S, which is produced by
smooth muscle cells and induces angiogenesis [18] and
coagulation factor XIII, a platelet and monocyte protein
that is involved with fibrin crosslinking and clot matura-
tion and that increases endothelial cell migration and pro-
liferation [19].
The expression of genes in 4 clusters was increased most
on days 4 and 8 post-wound (Figure 3, clusters 1, 5, 6, and
7). These "late" wound healing genes included markers of
tissue repair, angiogenesis, and further progression of
immune response. Tissue repair/remodeling genes whose
expression was increased included type IV collagen and
collagen modifying enzymes (procollagen C-endopepti-
dase enhancer and procollagen-lysine, 2-oxoglutarate 5-
dioxygenase) and the integrin β5. Angiogenesis genes
whose expression was increased included matrix metallo-
protease 9 (MMP-9) and granulin or progranulin. Pro-
granulin is a pluripotent growth factor that promotes cell
proliferation, cell motility, granulation and angiogenesis
[4]. Immune response genes among the late wound heal-
ing genes included several MHC class II molecules and
complement component 1q.
Genes differentially expressed between pre and post wound skin biopsiesFigure 1
Genes differentially expressed between pre and post wound skin biopsies. One skin punch biopsy was obtained pre 
wound and one either day 2, 4, or 8 post wound from 14 subjects. The 1,749 genes found to be differentially expressed using 
paired t-test comparison (p < 0.05) were analyzed by filtering (genes expressed in 80% of samples and at least more increased 
2 or more fold) and this yielded 753 genes. Supervised hierarchical clustering analysis of Eisen of the 753 differentially 
expressed genes revealed 7 signature clusters (Figure 1a). The genes in the 7 clusters were combined and analyzed again by 
supervised hierarchical clustering (Figure 1b). The pre wound biopsies are indicated by the blue bar, the day 2 post wound 
biopsies by the yellow bar, the day 4 post wound biopsy by the purple bar, and the day 8 post wound biopsy by the orange bar 
(Figure 1c).Page 4 of 11
(page number not for citation purposes)
Journal of Translational Medicine 2007, 5:11 http://www.translational-medicine.com/content/5/1/11The expression of genes in signature cluster 2 were
reduced in all post-wound samples (Figure 4). The down-
regulated cluster included endothelian-1 which is a vaso-
constrictor suggesting that vasodilation and increased
blood flow is an important aspect of wound healing.
The 753 genes included, in addition to the 7 time-depend-
ent signatures, another 131 genes involved in tissue
repair/remodeling, proliferation, inflammation, or
immune response according to DAVID [13] and Gene
Cards [14] mining tools. Supervised hierarchical cluster-
ing of the 131 transcripts emphasized the differential
kinetics of their appearance. Genes were thus segregated
into three groups: early transcripts, late transcripts and
transcript whose expression remained sustained inde-
pendently of time (Figure 5 and see additional file 1).
The early group of genes whose expression was increased
most on day 2 included several leukocyte markers; the leu-
kocyte adhesion molecules CD11C, CD44, and CXCR4
and the macrophage marker CD68. In addition, this
group included type 1 TGF-β.
The late group of genes whose expression was increased
most on days 4 and 8 included several leukocyte genes, IL-
10 receptor β chain, and MMP-2, and genes associated
with tissue repair, type 5 collagen, procollagen, connec-
tive tissue growth factor, and integrin αv. The expression
of the endothelial cell tight junction protein CD99 was
also increased and the tissue repair proteins ADAMTS3
and ADAM15.
The largest cluster was made up of genes whose expression
was increased at all time points in post-wound samples.
Signature clusters of genes whose expression was changed early in wound healingFigure 2
Signature clusters of genes whose expression was changed early in wound healing. Genes in signature clusters 3 
and 4 whose expression was greatest on day 2 are shown. Pre and post wound biopsies are color coded by the horizontal bars 
as per figure 1.Page 5 of 11
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including several proteasomes, interferon-inducible pro-
teins, mitogen-activated protein kinases, and HLA class I
and II molecules as well as CD6, MMP-11, macrophage
migration inhibitory factor (MIF), PECAM-1, lactoferrin,
and toll-like receptor 1. In addition, the expression of cap-
sases, death effector domain, tissue inhibitor of metallo-
protease -1 (TIMP1), and TIMP2 were also increased. This
group included markers of repair including collagen,
urokinase type plasminogen activator and hypoxia-induc-
ible factor (HIF). HIF is a nuclear transcription factor
whose expression is increased in endothelial cells and that
stimulates the expression of VEGF and hence angiogenesis
[1]. In addition, the expression of HSPA1B (HSP70)
which accelerates wound healing was also increased [20].
Comparison of markers of M1 and M2 macrophages
Several macrophage markers were expressed both early
and late in wound healing. During many inflammatory
processes macrophages have been found to be polarized
as M1 or M2 macrophages [21-24]. To determine the
polarization of the macrophage activation, all macro-
phage genes whose expression changed were selected, (see
additional file 2) and supervised hierarchical clustering
was used to analyze the expression of these M1 and M2
macrophage genes in the pre- and post-wound samples
from all 14 subjects. This information was compared to
reported assignment of genes to M1 or M2 according to
the literature [21,22]. Two clusters of genes were identi-
fied. One cluster contained genes whose expression was
increased early, on day 2, and the other genes whose
Signature clusters of genes whose expression was changed late in wound healingFigure 3
Signature clusters of genes whose expression was changed late in wound healing. Genes in signature clusters 1, 5, 
6, and 7 whose expression was greatest on days 4 and 8 are shown. Pre and post wound biopsies are color coded by the hor-
izontal bars as per figure 1.Page 6 of 11
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The early cluster was made up of 18 genes and included a
mix of M1 and M2 markers; eleven M1 markers and seven
M2 markers. In contrast, the late expressed genes were pre-
dominantly M2 markers with nine M2 markers and one
M1 marker.
Discussion
The wound healing process occurring in lesions of basal
cell carcinoma was evaluated on days 2 through 8 after a
cutaneous punch biopsy wound. We found that wound
healing is more than a simple orderly progression of cells
involved with acute inflammation and tissue repair. The
classically described model of wound healing states that
by day 2, the hemostasis phase of wound healing should
be complete. Days 2 through 8 should include the classi-
cal inflammatory, proliferative, and repair phases. How-
ever, we found no distinct separation between
inflammation, repair, remodeling, proliferation and ang-
iogenesis. Instead, we found that acute wound healing
was associated with a storm of transcripts involved in
repair, remodeling and inflammation and angiogenesis
which increased at all time points.
Nearly all genes whose expression changed were up regu-
lated, and most of these upregulated genes were involved
with inflammation. We identified 3 different groups of
genes whose expression was increased. The largest group
included those whose expression was increased through-
out the study period and was made up predominantly of
inflammatory transcripts. This group included markers of
a wide variety of leukocytes including macrophages, gran-
ulocytes, T cells, NK cells, and B cells. Markers of tissue
repair and angiogenesis were also expressed throughout
the study, although to a much lesser extent than the
inflammatory transcripts.
The second and third groups consisted of genes whose
expression was transiently increased after wound inflic-
tion. The expression of an early group of markers was
greatest on day 2 and the expression of the other group of
markers was greatest on days 4 and 8. Both groups of
genes included a mix of markers of inflammation, repair
and angiogenesis, however, inflammation markers were
predominant in the early group and repair and angiogen-
esis markers in the later group.
Classical models view wound healing as being directed
largely by cytokines and growth factors [2]. Our study sug-
gests that both the presence and phenotype of macro-
phages bears consideration in wound healing as a
potentially guiding element in normal repair.
The expression of a number of macrophage genes were
increased throughout the study. Macrophages are potent
producers of cytokines and growth factors and are known
to play important roles in autoimmunity, defense against
infection, response to cancer, tissue repair, tissue remode-
ling and angiogenesis. Macrophages also have diverse
phenotypes [21,22,25]. M1 polarized macrophages are
important in inflammation. They are potent effector cells
that produce large quantities of proinflammatory
cytokines and kill microorganisms and cancer cells [22].
M2 macrophages tune the inflammatory responses, scav-
enge debris, and promote angiogenesis, tissue remodeling
and repair [22]. We found that the profile of macrophage
related transcripts changed from a mixture of M1 and M2
genes early in wound healing to primarily M2 genes later.
Interestingly, Martinez and colleagues have found that
monocytes in the presence of macrophage colony-stimu-
lating factor (M-CSF), a growth factor found at high con-
centrations in blood from healthy subjects, drift forward a
M2 phenotype suggesting that M2 may be a default path-
way of macrophage differentiation [26]. Early in wound
healing M1 macrophages likely direct an inflammatory
response that helps clear the wound of microbes, cellular
deébris, and damaged matrix and M2 macrophages initi-
ate repair and angiogenesis. Late in wound healing, the
dominant M2 macrophages continue to direct tissue
repair and angiogenesis. One type of M2 macrophage,
Genes whose post wound expression was decreased on all daysFigure 4
Genes whose post wound expression was decreased on all days. The expression of genes in signature cluster 2 were 
decreased on all days. Pre and post wound biopsies are color coded by the horizontal bars as per figure 1.Page 7 of 11
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[21,22,25]. It may be that macrophages rather than TGF-β
and VEGF drive the change in wound healing from a pri-
mary inflammatory process to one of repair, angiogenesis,
and remodeling.
The conclusions that can be drawn from this study are
somewhat limited since gene expression analysis was
done on punch biopsies derived from skin with basal cell
carcinoma. Previous studies have concluded that cancer
cells are wounds that never heal [27] and that prior to the
wound, skin with basal cell carcinoma would be expected
to contain both inflammatory cells and cells involved
with remodeling, repair, and angiogenesis. Against this
background of inflammation, angiogenesis and remode-
ling that occurs with cancer, our study may not have been
able to detect some gene expression changes associated
with wound healing occurring in normal tissue. In fact,
this background of healing and inflammation associated
with the basal cell carcinoma may explain the inability of
Supervised Eisen hierarchical clustering analysis of 133 differentially expressed genes between pre and post wound that were not included in the signature l sFigu e 5
Supervised Eisen hierarchical clustering analysis of 133 differentially expressed genes between pre and post 
wound that were not included in the signature clusters. From the 753 differentially expressed genes, the genes in the 
signature clusters were removed and genes important in inflammation, immune response and wound healing were selected 
according to DAVID [13] and Gene Cards [14] and analyzed by supervised hierarchical clustering. Three clusters were identi-
fied; one whose expression was increased most on day 2, one on days 4 and 8, and another whose expression was increased 
on day 2–8. The specific genes are shown in additional file 2. Pre and post wound biopsies are color coded by the horizontal 
bars as per figure 1.Page 8 of 11
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post-wound samples. We compared changes in gene
expression in the healing skin with a pre wound sample of
skin with basal cell carcinoma rather than with normal
skin. While the differences detected likely reflect changes
due to healing rather than responses to the basal cell car-
cinoma, these observations should be confirmed in heal-
ing normal skin.
Despite the limitations of this study, our results expand
the current understanding of wound healing by offering a
snapshot of the concomitantly occurring transcriptional
events that characterize the overlapping phases of this bio-
logical process. In addition, our results confirm previous
reports describing the occurrence of several crucial factors
involved wound healing which we have found highly
upregulated at the mRNA level. We found that the expres-
sion of several genes previously noted to be involved with
wound healing, angiogenesis and tissue repair were
increased. These genes included S100A, progranulin,
MMP-9, αv integrin, β5 integrin, metallothioneins, and
connective tissue growth factor.
Early in wound healing S100A4 expression was increased.
S100A4 belongs to the S100 family of calcium binding
proteins. It is produced by macrophages, leukocytes,
fibroblast and endothelial cells [28]. Extracellular S100A4
is involved with angiogenesis and the remodeling of extra-
cellular matrix. It is involved with tumor progression and
may contribute to synovium hyperplasia in rheumatoid
arthritis [28].
An important wound healing growth factor progranulin
was among the late expressed genes. Progranulin is also
known as granulin or epithelin precursor, acrogranin, and
PC-derived growth factor [4]. Progranulin is a pluripoten-
tial growth factor that promotes tissue granulation and
neovascularization [4,29]. Progranulin activates extracel-
lular kinases. It is expressed on many tissues throughout
the body especially by epithelial cells undergoing rapid
Analysis of the expression of macrophage genesFigure 6
Analysis of the expression of macrophage genes. Genes characteristic of M1 and M2 macrophages were selected 
according to a list of transcripts reported in the literature [21,22,25] to be modulated by these cell subsets and were analyzed 
by supervised hierarchical clustering which revealed two clusters. The first cluster was a mix of M1 and M2 genes whose 
expression was greatest on day 2. The second cluster was predominantly M2 genes and their expression was greatest on day 4 
and 8. Pre and post wound biopsies are color coded by the horizontal bars as per figure 1.Page 9 of 11
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els are upregulated in the dermis for at least 10 days fol-
lowing the wound [29]. The administration of
progranulin to wounds prolongs neutrophil infiltration
and increases the accumulation of fibroblasts and blood
vessels in the wound by promoting dermal fibroblast and
endothelial cell proliferation and their migration to type I
collagen [29].
MMP-9 was also among the late expressed genes. MMP-9
is a metalloproteinase which promotes angiogenesis indi-
rectly by making VEGF more available to its receptor.
MMP-9 has been shown to promote angiogenesis in can-
cers [30]. The enhanced expression of MMP-9 during days
4 through 8 of wound healing suggests that it may also
contribute to angiogenesis during wound healing.
Other wound healing genes whose expression we found
to be increased late were the integrins αv and β5. The
integrin αv is important in angiogenesis, fibroblast migra-
tion and wound closure. αvβ5 is a receptor for vitronectin
and αvβ3 is a receptor for both fibronectin and vitronec-
tin. Both αvβ3 and αvβ5 play a major role in blood vessel
formation in cancer, arthritis, and ischemic retinopathy
[31]. Fibroblast migration to an angiogenic factor CYN61
is mediated by αvβ5. In addition during normal wound
healing fibroblasts differentiate into myofibroblasts in
granulation tissue where they play a role in wound con-
traction and scar formation [32]. The development of
myofibroblasts is dependent on αvβ3 and αvβ5 [32].
Connective tissue growth factor (CTGF) or CCN2 [33,34]
is an important wound healing growth factor that pro-
motes fibrosis. CCN2 is not normally expressed in dermal
fibroblasts, but during wound healing fibroblasts express
CCN2. In this study the expression of CCN2 was increased
on days 4 and 8. CCN2 promotes matrix deposition,
fibrobast proliferation and fibroblast adhesion.
The expression of three methallothioneins, methal-
lothionein 1G, 2A and G, were increased throughout the
study [35]. Methallothioneins are a family of cysteine-rich
low molecular weight proteins that bind trace metals
including zinc and copper. The expression of methal-
lothioneins is increased in metabolically active and prolif-
erating cells of the dermis. In skin wounds the levels of
methallothioneins are increased in the wound margin
where mitotic activity is increased. Methallothioneins are
thought to promote cell proliferation and re-epithelializa-
tion through its zinc and copper binding properties [35].
In conclusion, cutaneous wounds are initially associated
with increased expression of genes involved with all
aspects of inflammation and repair. Over the course of
healing the profile of genes expressed changes from pre-
dominantly inflammation to one of repair and angiogen-
esis. This shift in gene profile may reflect at least in part
the participation of M2 macrophages.
Additional material
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